Associate Editor Instructions: Difference between revisions - Compendium of Cancer Genome Aberrations

Line 19:

#Review the content for accuracy and appropriate completeness.

#Prioritize use of the tables, including helping the author convert the content or doing so yourself if applicable. If a table is not needed based on current knowledge, leave it in but add the words "not applicable" and remove any "examples" text.

#Ensure the authors have inserted references in the standard format using the PubMed extension.

#Ensure the authors have inserted references in the standard format using the PubMed extension, and that no references have been repeated in the reference list.

#Ensure ~~the~~ under construction ~~note at the top of~~ the page has been removed.

#Ensure any under construction notes or instructional text on the page has been removed.

#Ensure appropriate and helpful images are included. Note: [Mailto:Agiguere.hmr@ssss.gouv.qc.ca <u>Amélie Giguère, Ph.D, FCCMG</u>] has offered to provide images for rare chromosomal translocations in hematological malignancies and most anomalies in WHO 2017.

@@ Line 19: / Line 19: @@
 #Review the content for accuracy and appropriate completeness.
 #Prioritize use of the tables, including helping the author convert the content or doing so yourself if applicable.  If a table is not needed based on current knowledge, leave it in but add the words "not applicable" and remove any "examples" text.
-#Ensure the authors have inserted references in the standard format using the PubMed extension.
+#Ensure the authors have inserted references in the standard format using the PubMed extension, and that no references have been repeated in the reference list.
-#Ensure the under construction note at the top of the page has been removed.
+#Ensure any under construction notes or instructional text on the page has been removed.
 #Ensure appropriate and helpful images are included.  Note: [Mailto:Agiguere.hmr@ssss.gouv.qc.ca <u>Amélie Giguère, Ph.D, FCCMG</u>] has offered to provide images for rare chromosomal translocations in hematological malignancies and most anomalies in WHO 2017.